Sunil Agarwal

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Novato, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Ben Harshbarger, as attorney-in-fact for Sunil Agarwal
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Sunil Agarwal

Form 4 holding Director

ARVINAS, INC.

Security class
Stock Option (right to buy)
Shares / value
23,105
Estimated value
$145,120
Report date
25 Jun 2025
Price
$16.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP, Head of Development & CMO

Sana Biotechnology, Inc.

Security class
Stock Options (Right to Buy)
Shares / value
250,000
Estimated value
Report date
03 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Calithera Biosciences, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
20,000
Estimated value
Report date
01 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Sunil Agarwal

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .